scispace - formally typeset
A

Agnieszka E. Gorska

Researcher at Vanderbilt University

Publications -  47
Citations -  6426

Agnieszka E. Gorska is an academic researcher from Vanderbilt University. The author has contributed to research in topics: Transforming growth factor & Transforming growth factor beta. The author has an hindex of 29, co-authored 45 publications receiving 5927 citations. Previous affiliations of Agnieszka E. Gorska include Vanderbilt University Medical Center.

Papers
More filters
Journal ArticleDOI

TGF-ß Signaling in Fibroblasts Modulates the Oncogenic Potential of Adjacent Epithelia

TL;DR: TGF-β signaling in fibroblasts modulates the growth and oncogenic potential of adjacent epithelia in selected tissues and is associated with intraepithelial neoplasia in prostate and invasive squamous cell carcinoma of the forestomach.
Journal ArticleDOI

Abrogation of TGFβ signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis

TL;DR: It is demonstrated that Gr-1+CD11b+ myeloid cells are recruited into mammary carcinomas with type II TGF beta receptor gene (Tgfbr2) deletion and directly promote tumor metastasis.
Journal ArticleDOI

Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-β signaling in cooperation with active Kras expression

TL;DR: The data show that blockade of TGF-beta signaling and activated Ras signaling cooperate to promote PDAC progression, which indicated a haploinsufficiency of T GF- beta signaling in this genetic context.
Journal ArticleDOI

Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung

TL;DR: Inhibition of Gr-1+CD11b+ cells could normalize the premetastatic lung environment, improve host immunosurveillance, and inhibit tumor metastasis.
Journal ArticleDOI

Mammary tumor suppression by transforming growth factor beta 1 transgene expression

TL;DR: It is demonstrated that overexpression of TGF-alpha 1 in vivo can markedly suppress mammary tumor development and that MMTV-TGF-beta 1 transgenic mice are resistant to 7,12-dimethylbenz[a]anthracene-induced mammary tumors.